© TOBY MELVILLE/Reuters/Corbis Pharmaceuticals Breaking Down GlaxoSmithKline’s Billion-Dollar Wrongdoing By Alexandra Sifferlin What the drug company did to promote Paxil, Wellbutrin and Avandia illegally — and what it meant for patients